Market Research Industry Reports

Amgen Inc (AMGN) - Financial and Strategic SWOT Analysis Review

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Amgen Inc (AMGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Amgen Inc (Amgen) is a biotechnology company that discovers, develops, manufactures and markets innovative human therapeutics to improve the lives of patients suffering from serious diseases. It develops novel medicines in six focused therapeutic areas including cardiovascular disease, oncology/hematology, inflammation, bone health, neuroscience and nephrology. The company develops products by using advanced human genetics to unravel the difficulties of disease and understand the fundamentals of human biology. Amgen sells its products primarily to pharmaceutical wholesale distributors in the US. It also markets certain products directly to consumers by television advertising, direct-to-consumer print and multi-channel marketing. Amgen is headquartered in Thousand Oaks, California, the US.

Amgen Inc Key Recent Developments

Feb 01,2018: Amgen Reports Fourth Quarter And Full Year 2017 Financial Results
Jan 2,2018: Frontiers in Physiology Publishes Research Showing Pro-Arrhythmia Risk Predictivity of Adult Human Primary Ventricular Tissue-Based Model
Jan 09,2018: BC Platforms to Provide Big Data Driven Research Solutions to Amgen in Cardiovascular Diseases and Oncology
Dec 12,2017: Amgen Announces 15 Percent Increase In 2018 First Quarter Dividend
Dec 11,2017: Amgen Foundation Pledges Up To $500,000 In Relief To Victims Of The Southern California Wildfires

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


List of Tables 5
List of Figures 5
Section 1 - About the Company 6
Amgen Inc - Key Facts 6
Amgen Inc - Key Employees 7
Amgen Inc - Key Employee Biographies 9
Amgen Inc - Major Products and Services 10
Amgen Inc - History 11
Amgen Inc - Company Statement 20
Amgen Inc - Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Joint Venture 28
Section 2 Company Analysis 29
Company Overview 29
Amgen Inc - Business Description 29
Business Segment: Human Therapeutics 29
Overview 29
Performance 29
Key Stats 0
Business Segment: Other Revenues 0
Performance 0
Business Segment: Other Segment 0
Overview 0
Geographical Segment: Rest of the world (ROW) 0
Performance 0
Geographical Segment: United States 0
Performance 0
R&D Overview 1
Amgen Inc - Corporate Strategy 2
Amgen Inc - SWOT Analysis
SWOT Analysis - Overview
Amgen Inc - Strengths
Amgen Inc - Weaknesses 4
Amgen Inc - Opportunities 5
Amgen Inc - Threats 6
Amgen Inc - Key Competitors 7
Section Company Financial Ratios 8
Financial Ratios - Annual Ratios 8
Performance Chart 41
Financial Performance 41
Financial Ratios - Interim Ratios 42
Financial Ratios - Ratio Charts 4
Section 4 Companys Lifesciences Financial Deals and Alliances 44
Amgen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 44
Amgen Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 45
Amgen Inc, Recent Deals Summary 46
Section 5 Companys Recent Developments 47
Feb 01, 2018: Amgen Reports Fourth Quarter And Full Year 2017 Financial Results 47
Jan 2, 2018: Frontiers in Physiology Publishes Research Showing Pro-Arrhythmia Risk Predictivity of Adult Human Primary Ventricular Tissue-Based Model 50
Jan 09, 2018: BC Platforms to Provide Big Data Driven Research Solutions to Amgen in Cardiovascular Diseases and Oncology 51
Dec 12, 2017: Amgen Announces 15 Percent Increase In 2018 First Quarter Dividend 52
Dec 11, 2017: Amgen Foundation Pledges Up To $500,000 In Relief To Victims Of The Southern California Wildfires 5
Dec 07, 2017: New Data To Be Presented At ASH 2017 Underscore Amgens Commitment To Improving Lives And Changing Outcomes For Patients With Difficult-To-Treat Blood Cancers 54
Oct 25, 2017: Amgen Reports Third Quarter 2017 Financial Results 56
Oct 24, 2017: Amgen Announces Appointment Of Wanda M. Austin To Board Of Directors 58
Oct 06, 2017: Amgen And LabCentral Open Nomination Process For Lab Residency 59
Sep 25, 2017: Amgen Provides Update On Hurricane Maria 60
Section 6 Appendix 61
Methodology 61
Ratio Definitions 61
About GlobalData 65
Contact Us 65
Disclaimer 65

List Of Tables

List of Tables
Amgen Inc, Key Facts 6
Amgen Inc, Key Employees 7
Amgen Inc, Key Employee Biographies 9
Amgen Inc, Major Products and Services 10
Amgen Inc, History 11
Amgen Inc, Other Locations 22
Amgen Inc, Subsidiaries 24
Amgen Inc, Joint Venture 28
Amgen Inc, Key Competitors 37
Amgen Inc, Annual Ratios 38
Amgen Inc, Annual Ratios (Cont...1) 39
Amgen Inc, Annual Ratios (Cont...2) 40
Amgen Inc, Interim Ratios 42
Amgen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 44
Amgen Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 45
Amgen Inc, Recent Deals Summary 46
Currency Codes 61
Capital Market Ratios 61
Equity Ratios 62
Profitability Ratios 62
Cost Ratios 63
Liquidity Ratios 63
Leverage Ratios 64
Efficiency Ratios 64

List Of Figures

List of Figures
Amgen Inc, Performance Chart (2013 - 2017) 41
Amgen Inc, Ratio Charts 43
Amgen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 44
Amgen Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 45

Amgen Inc Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Amgen Inc Company Profile is a detailed strategic and analytical report on Amgen Inc. The 2018 version of the report offers detailed insights into the companys strategies, developments, outlook and

USD 200View Report

Amgen Inc (AMGN) - Financial and Strategic SWOT Analysis Review

Amgen Inc (AMGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData

USD 125View Report

Amgen Inc Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Amgen Inc Company Profile is a detailed strategic and analytical report on Amgen Inc. The 2018 version of the report offers detailed insights into the companys strategies, developments, outlook and

USD 200View Report

Amgen Inc Strategic Analysis Review- Amgen Inc SWOT, Outlook, Operations and Financial Profile

Amgen Inc Company Profile provides strategic analysis of Amgen Inc Company in current market conditions. The companys business/ operational/growth strategies are analyzed in the unique research work. Growth opportunities available

USD 200View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 125
  • Site Licence    USD 250
  • Enterprise Wide Licence    USD 375
$ 125

Reports Details

Published Date : Feb 2018
No. of Pages :65
Country :United States of America
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube